Skip to main navigation Skip to search Skip to main content

Double autophagy stimulation using chemotherapy and mTOR inhibition combined with hydroxychloroquine for autophagy modulation in patients with relapsed or refractory multiple myeloma

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)e261-e265
JournalHaematologica
Volume102
Issue number7
DOIs
StatePublished - Jun 26 2017

Funding

University of Pennsylvania Institutional Clinical and Translational Science Award Research Center grant (UL1 RR024134) (ECS), The Knight Cancer Institute RAC CCSG P30CA069533 (ECS), OCTRI (Oregon clinical translational research institute) resources (ECS), M. D. Anderson Cancer Center SPORE in Multiple Myeloma Developmental Research Program (DTV), The Abramson Cancer Center pilot grant #IRG-78-002-31 (DTV), NCI Cancer Clinical Investigator Team Leadership Award 5P30CA069533-17 (ECS).

FundersFunder number
Knight Cancer InstituteRAC CCSG P30CA069533
University of Pennsylvania Institutional Clinical and Translational Science Award Research CenterUL1 RR024134
National Institute of Health-National Cancer Institute5P30CA069533-17, P30CA016520
Oregon Clinical and Translational Research Institute
Abramson Cancer Center#IRG-78-002-31

    ASJC Scopus subject areas

    • Hematology

    Cite this